By determining the infection rate at the indicated time points, we found that preincubating VSV-SARS-CoV-2 with the FXa-Fc fusion protein significantly inhibited viral infection in a dose-dependent manner (from 62.5 nM to 1 μM) (Fig. 1g and Supplementary Fig. 4a). The gene discussed is F10; the disease is viral infectious disease.